Ambiq Micro, Inc. (AMBQ)

Ambiq designs systems on a chip, meaning most of a computer on one piece of silicon, built to run on very little power. Its platform is called SPOT, short for Sub-threshold Power Optimized Technology: a set of design techniques that run ordinary transistors below the voltage at which they normally switch on, which the company says cuts power use by two to five times against conventional chip designs. Two families carry it. Apollo, proven over five generations, pairs a host processor with a rich set of peripherals for AI work done in software or with vector acceleration. Atomiq, whose first product is still in development, is meant to add a full neural processing unit, a block of silicon dedicated to running AI models. The chips ship with software: the AmbiqSuite development kit, modules for graphics, Bluetooth and security, and neuralSPOT for AI. 16171819202122

How it operates

Ambiq designs systems on a chip, meaning most of a computer on one piece of silicon, built to run on very little power. Its platform is called SPOT, short for Sub-threshold Power Optimized Technology: a set of design techniques that run ordinary transistors below the voltage at which they normally switch on, which the company says cuts power use by two to five times against conventional chip designs. Two families carry it. Apollo, proven over five generations, pairs a host processor with a rich set of peripherals for AI work done in software or with vector acceleration. Atomiq, whose first product is still in development, is meant to add a full neural processing unit, a block of silicon dedicated to running AI models. The chips ship with software: the AmbiqSuite development kit, modules for graphics, Bluetooth and security, and neuralSPOT for AI. 16171819202122

The chips go into things people wear and places that cannot easily be wired: smartwatches and fitness trackers, augmented and virtual reality glasses, smart rings, digital health monitors, security systems and access control, livestock tracking, crop monitoring and factory automation. Body-worn devices drive a significant portion of revenue today, and they often need weeks of battery life while running AI features. The company says its products power over 290 million devices, and that in 2025 over 80% of them ran AI algorithms. 232425

Ambiq sells to more than 200 end customers, mostly through third-party distributors and, to a lesser extent, through resellers and its own sales force. The money sits in very few of them. Three end customers each took a tenth or more of net sales in 2025: Customer E at about 36%, Customer F at about 29% and Customer G at about 20%. The top five took 91% of net sales and the top ten 95.6%. The largest alone was about 35.6%, against 40.9% the year before. The distributors concentrate too: Distributor B and Distributor C took about 21% and 20% of net sales. Purchase orders rather than long-term agreements carry the business, and they typically arrive 16 weeks before the delivery date, stretching to 36 weeks when supply is tight. 262728293031

Where the goods land and where they are used are two different maps. The note in the accounts that splits net sales by country does so by the country the products were shipped to, which the filing says may be different from where the ultimate end customers sit. On that basis China took 42.3% of 2025 revenue, Taiwan 35.6%, Other Countries 12.0% and Singapore 10.1%. Counted instead by the headquarters of the ultimate end customer, the picture inverts: net sales from end customers in the United States reached 85.5% in 2025, up from 48.1%, while Mainland China fell to 8.6% from 50%. Sales staff and field application engineers sit near customers in Germany, Japan, Mainland China, Poland, Singapore, Taiwan and the United States. 32333435

Ambiq owns no factory. It is fabless, meaning it designs its chips and hires others to make them, and the filing says it depends on a single third-party supplier for wafer fabrication. That supplier is TSMC, which has made its chips since the founding, on 180-nanometer, 90-nanometer, 40-nanometer, 22-nanometer and 12-nanometer processes, all of them mature lines rather than the newest and costliest. Packaging and testing go to the ASE group, King Yuan Electronics Group and Sigurd, in Taiwan and Mainland China. Foundry agreements generally carry no volume commitment and work off purchase orders; at the end of 2025 manufacturing purchase commitments stood at 10.7 million dollars. 36373839

The specifics

SPOT is the whole argument. Running transistors below and near the threshold voltage, at 0.4, 0.5 or 0.6 volts instead of the standard 0.8 or 0.9, costs significantly more to design, the filing says, but it lets Ambiq build on cheap mature processes rather than the advanced ones other chipmakers use to chase lower power. The company protects the method as patents and trade secrets: as of January 14, 2026 it owned 57 issued United States patents, 11 issued foreign patents, 13 pending United States applications and six pending foreign applications, and the issued American patents expire from 2033 through 2042. It licenses some technology from others as well, usually non-exclusively, and says no single third-party licence is significant to the business. 40414243

The filing names its rivals without hedging: large microcontroller vendors including Infineon, Microchip, NXP, Silicon Laboratories, STMicroelectronics and Texas Instruments; the connectivity chip makers Nordic Semiconductor, Renesas and Synaptics; and Qualcomm, which it says it sometimes competes with and sometimes works alongside on the same design. It argues it holds its own because SPOT makes its parts far less power hungry than the alternatives, and because standard CMOS manufacturing lets it supply quickly enough for customers to hit their own launch dates. Against that it states its handicaps plainly: a relatively short operating history in some of its markets, and a smaller size and customer base than many competitors. 4445

Ambiq became a public company in 2025. The offering closed on July 31, 2025, with 4,600,000 shares sold including the underwriters' option in full for 600,000 more, and brought net proceeds of 102.7 million dollars after underwriting discounts and commissions of 7.7 million; the preferred stock then outstanding converted into 12,729,240 common shares. A follow-on offering of 2,679,600 shares closed on January 26, 2026 and brought net proceeds of 76.8 million dollars. The year ended with 140.3 million dollars in cash and an accumulated deficit of 356.7 million, and the company says its cash on hand and anticipated cash from operations will be sufficient to finance operations for at least the next twelve months. 464748495051

Two other things shape the paperwork. Preparing the 2024 and 2023 accounts, the company found a material weakness in its internal control over financial reporting, in the segregation of certain accounting duties and in information technology controls; it put in a new financial system and extra layers of review, and says the weakness was fully remediated as of December 31, 2025. And the rules keep moving: the filing notes that the United States Department of Commerce keeps tightening export controls and adding firms to the Entity List, which would force Ambiq to obtain licences before selling to a listed customer or buying from a listed supplier, while Colorado's Artificial Intelligence Act takes effect on June 30, 2026 and the European Union's AI Act carries fines of up to the greater of 35 million euros or 7% of worldwide annual turnover. 5253545556

What drives growth, line by line

Net sales fell 4.7% in 2025, to 72.5 million dollars from 76.1 million, and the filing presents the fall as a swap rather than a slump. Sales to end customers outside Mainland China rose to 66.3 million dollars from 38.1 million, while sales to end customers inside Mainland China dropped to 6.2 million from 38.0 million; the company attributes both moves to a strategic prioritization of sales to higher margin opportunities. Gross profit rose 32.1% to 32.1 million dollars, and gross margin widened to 44.3% from 31.9%. 57585960

China. The largest line, at 30.7 million dollars, 42.3% of revenue, down 44.0% from 54.7 million the year before. Because the country split is drawn by where the goods were shipped, this line follows distribution into Mainland China rather than demand there. The filing describes a deliberate decision to diversify away from low margin Mainland China customers and toward markets and customers where energy efficiency and edge AI performance are the differentiators; on the end customer count, Mainland China went to 9% of net sales from 50%. 323361

Taiwan. 25.8 million dollars, 35.6% of revenue, up 42.0% from 18.2 million. Taiwan is where much of the contract packaging and testing is done and where sales staff and field application engineers sit, so on a shipped-to basis this line rose as the business moved out of Mainland China. 323835

Other Countries. The fastest growing line: 8.7 million dollars, 12.0% of revenue, up 176.6% from 3.1 million. The filing's own table calls it Rest of the World and footnotes it as the countries individually under a tenth of sales. Counted by the headquarters of the ultimate end customer, net sales from the United States reached 85.5% of the total in 2025, up from 48.1%. 326234

Singapore. 7.3 million dollars, 10.1% of revenue, a line the shipped-to table carries with no figure at all against it for the year before. Sales staff and engineers were already there, and in January 2026 the company was due to start a three-year lease on Singapore office space with minimum payments of about 2.2 million Singapore dollars. 3262351563

What comes next, in the company's own words: it expects to spend more on research and development, on Apollo6, on Atomiq and on further variants within the existing Apollo families, to push deeper into medical and healthcare, the industrial edge and smart homes and buildings, and to move into automotive and data center computing. It also plans to turn SPOT into an intellectual property and chip development platform that other companies can license, including for building next generation AI data center chips. 6465

The read's section on the people who run it is on the People tab.

What the desk infers Inferred

1. Inferred

   The country split Ambiq reports is a map of its distribution channel, not of its customers: most of what ships into China, Taiwan and Singapore is bound for brands headquartered in the United States.

   Because

   • The table that splits net sales by country is drawn on the country the products were shipped to, which the filing says may be different from where the ultimate end customers sit. 33
   • On that shipped-to basis the record carries China at 42.3% of revenue, Taiwan at 35.6% and Singapore at 10.1%. 32
   • Counted by the headquarters of the ultimate end customer, net sales from the United States reached 85.5% in 2025 while Mainland China fell to 8.6%. 34
   • More than 200 end customers are served mostly through third-party distributors, and two of those distributors took about 21% and 20% of net sales. 2628
   Confidence 85 of 100Wrong if A filing showing end customers headquartered in China, Taiwan or Singapore accounting for most of net sales, or one that drops the warning that the shipped-to country differs from where the end customers sit.
2. Inferred

   The largest end customer, at about 35.6% of net sales, is most likely a maker of body-worn consumer devices rather than an industrial, medical or automotive buyer.

   Because

   • The filing says body-worn AI devices drive a significant portion of revenue today. 24
   • The markets it lists open with smartwatches and fitness trackers, augmented and virtual reality glasses and smart rings, before the industrial and farming uses. 23
   • One end customer accounted for about 35.6% of net sales in 2025 and 40.9% in 2024. 30
   • End customers headquartered in the United States accounted for 85.5% of net sales in 2025. 34
   • The products power over 290 million devices, a volume that fits consumer hardware rather than industrial equipment. 25
   Confidence 62 of 100Wrong if A filing, or a disclosure by the customer itself, naming Ambiq's largest end customer as an industrial, medical, automotive or data center buyer.
3. Inferred

   Ambiq's cost advantage rests on one foundry keeping older production lines open, so TSMC is a single point of failure that no second source presently covers.

   Because

   • The filing says the company depends on a single third-party supplier for the fabrication of semiconductor wafers. 36
   • That supplier is TSMC, which has made the chips since the founding, on 180-nanometer, 90-nanometer, 40-nanometer, 22-nanometer and 12-nanometer processes. 37
   • SPOT is what lets the products be manufactured at much more cost-effective process technology nodes instead of the expensive advanced ones. 41
   • Qualifying new contract manufacturers, and specifically semiconductor foundries, is described as time consuming and liable to bring unforeseen manufacturing and operations problems. 66
   Confidence 72 of 100Wrong if A filing naming a second foundry fabricating Ambiq's wafers in volume, or one moving its main products to a leading edge process node.

We are a pioneer and leading provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute – especially at the edge.

Our products power over 290 million devices today. In 2025, we estimate that over 80% of our products ran AI algorithms.

For the twelve months ended December 31, 2025 and 2024, we generated net sales of $72.5 million and $76.1 million, respectively, and a net loss of $36.5 million and $39.7 million, respectively. As of December 31, 2025, we had accumulated deficit of $356.7 million.

What it warns about, in its own words

• We have a history of net losses, and we may not achieve or maintain profitability in the future.
• We depend on a limited number of end customers for most of our revenue.
• We do not have long-term commitments from our end customers, and our end customers may cease purchasing our products at any time.
• We have no manufacturing capabilities of our own.
• Decreases in average selling prices of our products and increases in input costs may reduce our gross margins.